Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,776 | 780 | 99.3% |
| Education | $80.96 | 11 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,802 | 109 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,032 | 93 | $0 (2024) |
| Lilly USA, LLC | $1,010 | 67 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $951.62 | 55 | $0 (2024) |
| Novo Nordisk Inc | $840.36 | 55 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $811.89 | 60 | $0 (2024) |
| GlaxoSmithKline, LLC. | $557.20 | 32 | $0 (2024) |
| PFIZER INC. | $436.24 | 36 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $337.16 | 38 | $0 (2022) |
| Amarin Pharma Inc. | $291.29 | 23 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $998.24 | 45 | AstraZeneca Pharmaceuticals LP ($219.90) |
| 2023 | $1,062 | 55 | Boehringer Ingelheim Pharmaceuticals, Inc. ($209.29) |
| 2022 | $946.70 | 60 | Boehringer Ingelheim Pharmaceuticals, Inc. ($207.50) |
| 2021 | $1,380 | 96 | AstraZeneca Pharmaceuticals LP ($225.22) |
| 2020 | $1,824 | 128 | AstraZeneca Pharmaceuticals LP ($418.02) |
| 2019 | $2,055 | 163 | AstraZeneca Pharmaceuticals LP ($355.80) |
| 2018 | $1,471 | 112 | AstraZeneca Pharmaceuticals LP ($272.93) |
| 2017 | $2,120 | 132 | Merck Sharp & Dohme Corporation ($308.22) |
All Payment Transactions
791 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: VACCINES | ||||||
| 11/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Not Applicable | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.05 | General |
| 08/26/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $116.67 | General |
| Category: Obesity | ||||||
| 08/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: DIABETES | ||||||
| 08/06/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: PSYCHIATRY | ||||||
| 07/09/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: DIABETES | ||||||
| 06/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Obesity | ||||||
| 06/04/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 05/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: VACCINES | ||||||
| 05/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: DIABETES | ||||||
| 04/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,292 | 2,181 | $303,727 | $157,742 |
| 2022 | 17 | 1,517 | 2,332 | $327,857 | $175,544 |
| 2021 | 16 | 1,255 | 2,116 | $300,510 | $165,402 |
| 2020 | 19 | 1,304 | 2,224 | $310,110 | $142,553 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 958 | $153,800 | $88,873 | 57.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 166 | 166 | $41,500 | $22,425 | 54.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 146 | 148 | $18,500 | $10,851 | 58.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 45 | $11,250 | $5,965 | 53.0% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 64 | 102 | $25,500 | $5,958 | 23.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 14 | 66 | $9,900 | $5,695 | 57.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 86 | 88 | $2,640 | $2,587 | 98.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $2,700 | $2,064 | 76.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 104 | 104 | $6,240 | $2,058 | 33.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 90 | 92 | $3,220 | $1,989 | 61.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,300 | $1,896 | 57.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 24 | $2,880 | $1,556 | 54.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $5,200 | $1,377 | 26.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 113 | 127 | $6,985 | $1,266 | 18.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 44 | 71 | $4,615 | $1,221 | 26.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 72 | 117 | $1,755 | $982.80 | 56.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,300 | $770.31 | 23.3% |
| 90471 | Administration of vaccine | Office | 2023 | 13 | 13 | $442.00 | $208.32 | 47.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 395 | 1,068 | $170,880 | $105,337 | 61.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 159 | 159 | $39,766 | $22,061 | 55.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 144 | 150 | $18,750 | $11,656 | 62.2% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 96 | 155 | $38,750 | $9,771 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 33 | $8,250 | $3,943 | 47.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $3,300 | $3,240 | 98.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 101 | 101 | $3,030 | $2,969 | 98.0% |
About Dr. Vincent Codella, DO
Dr. Vincent Codella, DO is a Family Medicine healthcare provider based in Union, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134111248.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Codella, DO has received a total of $11,857 in payments from pharmaceutical and medical device companies, with $998.24 received in 2024. These payments were reported across 791 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($11,776).
As a Medicare-enrolled provider, Codella has provided services to 5,368 Medicare beneficiaries, totaling 8,853 services with total Medicare billing of $641,241. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Union, NJ
- Active Since 08/16/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134111248
Products in Payments
- FARXIGA (Drug) $1,302
- JARDIANCE (Drug) $1,163
- JANUVIA (Drug) $673.30
- XARELTO (Drug) $598.16
- TRULICITY (Drug) $446.37
- Ozempic (Drug) $369.45
- SYMBICORT (Drug) $310.03
- Edarbi (Drug) $295.98
- Vascepa (Drug) $291.29
- GalaFLEX (Device) $263.61
- ENTRESTO (Drug) $259.05
- Livalo (Drug) $210.98
- SHINGRIX (Biological) $194.27
- INVOKANA (Drug) $186.40
- BELSOMRA (Drug) $180.12
- REXULTI (Drug) $179.28
- VRAYLAR (Drug) $176.32
- MOUNJARO (Drug) $168.99
- Wegovy (Drug) $165.31
- TRELEGY ELLIPTA (Drug) $162.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Union
Melonie Proctor, Do, DO
Family Medicine — Payments: $13,943
Dr. Brian Walters, Md, MD
Family Medicine — Payments: $7,966
Dr. Corey Gallus, D.o, D.O
Family Medicine — Payments: $7,043
Dr. Jamie Borgmann, Md, MD
Family Medicine — Payments: $6,904
Michael Richardson, M.d, M.D
Family Medicine — Payments: $4,260
Dr. Craig Sanders, Do, DO
Family Medicine — Payments: $3,568